WINT
Windtree Therapeutics
WINT
WINT
Delisted
WINT was delisted on the 20th of August, 2025.
11 hedge funds and large institutions have $521K invested in Windtree Therapeutics in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Holders
11
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$35.7K | |
| 2 | +$35.7K | |
| 3 | +$17.9K | |
| 4 |
TSS
Two Sigma Securities
New York
|
+$17.9K |
Top Sellers
| 1 | -$53.6K | |
| 2 | -$35.7K | |
| 3 | -$35K | |
| 4 |
Renaissance Technologies
New York
|
-$17.9K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$17.9K |